221 related articles for article (PubMed ID: 8730404)
1. Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.
Sargent CA; Wilde MW; Dzwonczyk S; Tuttle JG; Murray HN; Atwal K; Grover GJ
Cardiovasc Res; 1996 Feb; 31(2):270-7. PubMed ID: 8730404
[TBL] [Abstract][Full Text] [Related]
2. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
3. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
4. The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts.
Grover GJ; Murray HN; Baird AJ; Dzwonczyk S
Eur J Pharmacol; 1995 Apr; 277(2-3):271-4. PubMed ID: 7493619
[TBL] [Abstract][Full Text] [Related]
5. The cardioprotective effect of naringenin against ischemia-reperfusion injury through activation of ATP-sensitive potassium channel in rat.
Meng LM; Ma HJ; Guo H; Kong QQ; Zhang Y
Can J Physiol Pharmacol; 2016 Sep; 94(9):973-8. PubMed ID: 27408985
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.
Grover GJ; Sleph PG; Dzwonczyk S
J Cardiovasc Pharmacol; 1990 Dec; 16(6):853-64. PubMed ID: 1704976
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
9. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
10. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891.
Grover GJ; Dzwonczyk S; Sleph PG
Eur J Pharmacol; 1990 Nov; 191(1):11-8. PubMed ID: 2128745
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury.
Ji Y; Pang QF; Xu G; Wang L; Wang JK; Zeng YM
Eur J Pharmacol; 2008 Jun; 587(1-3):1-7. PubMed ID: 18468595
[TBL] [Abstract][Full Text] [Related]
12. Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning.
Cao CM; Xia Q; Gao Q; Chen M; Wong TM
J Pharmacol Exp Ther; 2005 Feb; 312(2):644-50. PubMed ID: 15345753
[TBL] [Abstract][Full Text] [Related]
13. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury.
Zhu HF; Dong JW; Zhu WZ; Ding HL; Zhou ZN
Life Sci; 2003 Jul; 73(10):1275-87. PubMed ID: 12850243
[TBL] [Abstract][Full Text] [Related]
14. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
Xu D; Zhang S; Foster DJ; Wang J
Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
[TBL] [Abstract][Full Text] [Related]
15. Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts.
Sargent CA; Dzwonczyk S; Grover GJ
Pharmacology; 1992; 45(5):260-8. PubMed ID: 1465473
[TBL] [Abstract][Full Text] [Related]
16. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
Sargent CA; Vesterqvist O; McCullough JR; Ogletree ML; Grover GJ
J Pharmacol Exp Ther; 1992 Sep; 262(3):1161-7. PubMed ID: 1382129
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.
Sargent CA; Sleph PG; Dzwonczyk S; Normandin D; Antonaccio MJ; Grover GJ
J Cardiovasc Pharmacol; 1993 Oct; 22(4):564-70. PubMed ID: 7505358
[TBL] [Abstract][Full Text] [Related]
18. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart.
Gao Q; Pan HY; Qiu S; Lu Y; Bruce IC; Luo JH; Xia Q
Life Sci; 2006 Jun; 79(3):217-24. PubMed ID: 16458326
[TBL] [Abstract][Full Text] [Related]
19. Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
Gögelein H; Ruetten H; Albus U; Englert HC; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):33-41. PubMed ID: 11485036
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
